GUGLIESI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 3.921
EU - Europa 2.419
AS - Asia 1.539
AF - Africa 89
SA - Sud America 75
OC - Oceania 27
Totale 8.070
Nazione #
US - Stati Uniti d'America 3.870
IT - Italia 933
CN - Cina 484
SG - Singapore 410
IE - Irlanda 260
SE - Svezia 236
AT - Austria 174
DE - Germania 174
GB - Regno Unito 121
FR - Francia 104
FI - Finlandia 92
KR - Corea 92
JP - Giappone 81
IN - India 79
UA - Ucraina 76
HK - Hong Kong 70
SA - Arabia Saudita 66
ID - Indonesia 63
VN - Vietnam 61
SN - Senegal 48
CA - Canada 45
BE - Belgio 43
NL - Olanda 43
PL - Polonia 42
BR - Brasile 41
TR - Turchia 31
TW - Taiwan 26
AU - Australia 21
GR - Grecia 20
IL - Israele 18
CO - Colombia 17
DK - Danimarca 17
PK - Pakistan 17
ES - Italia 14
RU - Federazione Russa 13
NO - Norvegia 12
UG - Uganda 12
IR - Iran 11
CH - Svizzera 10
AR - Argentina 9
HR - Croazia 7
IQ - Iraq 6
LT - Lituania 6
MA - Marocco 6
NZ - Nuova Zelanda 6
PH - Filippine 6
TN - Tunisia 6
EC - Ecuador 5
BD - Bangladesh 4
JO - Giordania 4
MX - Messico 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
ZA - Sudafrica 4
ET - Etiopia 3
LU - Lussemburgo 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
EG - Egitto 2
PT - Portogallo 2
RS - Serbia 2
ZM - Zambia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
GH - Ghana 1
HU - Ungheria 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
TG - Togo 1
YE - Yemen 1
Totale 8.070
Città #
Chandler 679
Singapore 324
Santa Clara 269
Dublin 257
Beijing 160
Vienna 156
Fairfield 150
Houston 143
Torino 137
Ann Arbor 120
Sovicille 115
Ashburn 101
Turin 100
Nyköping 95
Woodbridge 83
Columbus 82
Jacksonville 82
Wilmington 75
Dearborn 70
Jakarta 63
Seattle 63
Cambridge 60
Princeton 60
Medford 58
Villeurbanne 58
Pisa 50
Guangzhou 48
Los Angeles 45
Redwood City 45
Dong Ket 44
New York 39
Fremont 38
Rome 38
Milan 37
Boston 36
Jeddah 35
Warsaw 33
Shanghai 32
Boardman 27
Washington 24
Mumbai 21
Pittsburgh 21
Lappeenranta 20
Brussels 19
Frankfurt am Main 19
Taipei 18
Helsinki 17
Nanjing 17
Florence 16
Munich 16
San Mauro Torinese 16
Gongju 15
Norwalk 15
Orange 15
San Diego 14
Ta'if 14
Hefei 13
Rochester 13
Tokyo 13
Aarhus 12
Baltimore 12
Hebei 12
Kampala 12
London 12
Maddaloni 12
Bogotá 11
Lahore 11
Philadelphia 11
Piemonte 11
Dallas 10
Hong Kong 10
Seoul 10
Thebes 10
Toronto 10
Novara 9
Nuremberg 9
Silver Spring 9
Tampa 9
Birmingham 8
Cardiff 8
Chicago 8
Hangzhou 8
Istanbul 8
Oslo 8
Phoenix 8
Tel Aviv 8
Central 7
Hanover 7
Ipswich 7
Kahramanmaraş 7
Medina 7
San Francisco 7
Wuhan 7
Alessandria 6
Antwerp 6
Berlin 6
Bologna 6
Brescia 6
Chengdu 6
Erlangen 6
Totale 4.800
Nome #
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 329
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells 307
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 247
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 243
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 230
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 197
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 195
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 194
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 189
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 184
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 177
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 166
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 160
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 149
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 146
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 141
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 139
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 135
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 132
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 126
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 124
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 122
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 117
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 117
Where do we stand after decades of studying human cytomegalovirus? 117
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 115
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 115
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 110
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 105
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 104
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 104
Bifunctional role of interferon inducible IFI16 protein inside and outside of endothelial cells 100
Tuning the Orchestra: HCMV vs. Innate Immunity. 97
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 95
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 94
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 94
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 91
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. [*Azzimonti B, *Dell'Oste V, co-first authors] 88
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 84
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 84
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 83
The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway 80
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 80
Anti-inflammatory and vascularprotective properties of 8-prenylapigenin. 80
The interferon-inducible IFI16 gene acts as a restriction factor for human citomegalovirus replication 79
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 79
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 78
Detection of IFI16 in body fluids 73
The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. 73
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 73
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 72
Targeting PAD-mediated citrullination to treat human papillomavirus infections 72
45th International Herpesvirus Workshop 72
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 68
Biotechnology, Industry and Research in Piemonte from 1990 to 2003 : an update 67
Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha 67
Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene 67
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 66
50° Congresso Nazionale della Società Italiana di Microbiologia 62
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 61
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 61
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding 60
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 59
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 57
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 50
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 48
Targeting PAD-mediated citrullination to treat human papillomavirus infections 48
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 48
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 46
HERPES SIMPLEX VIRUS TYPE 1 EXPLOITS LIPID METABOLISM: IMPLICATIONS FOR VIRAL INFECTIVITY AND ALZHEIMER’S DISEASE 45
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 41
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 38
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 35
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 35
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 33
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 33
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 33
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 28
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer 24
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 20
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 19
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 19
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 19
Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection 18
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 16
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 13
Totale 8.261
Categoria #
all - tutte 25.725
article - articoli 0
book - libri 0
conference - conferenze 15.677
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020240 0 0 0 0 0 0 0 0 66 64 46 64
2020/2021726 53 42 32 41 62 57 83 52 60 88 42 114
2021/2022835 65 22 53 82 35 30 32 35 35 63 234 149
2022/20231.853 99 109 29 237 201 423 91 152 268 55 89 100
2023/20241.039 142 154 74 51 90 105 49 68 22 65 82 137
2024/20251.687 83 267 222 210 406 180 140 137 42 0 0 0
Totale 8.261